ADAPTIMMUNE THERAPEUTICS PLC Stock Issued During Period, Value, Acquisitions
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ADAPTIMMUNE THERAPEUTICS PLC stock issued during period, value, acquisitions for the quarter ending 2023-06-30 was $60.76M.
- ADAPTIMMUNE THERAPEUTICS PLC stock issued during period, value, acquisitions for fiscal 2023 was $60.76M.
| Period end | Stock Issued During Period, Value, Acquisitions 3 month | Stock Issued During Period, Value, Acquisitions 12 month |
|---|---|---|
| 2023-12-31 | $60.76M 10-K · filed 2025-03-24 | |
| 2023-06-30 | $60.76M 10-Q · filed 2024-11-13 |